Max Robotics — Global Service Robot Directory + US Certification

About

Shuji Kameyama is a urological surgeon advancing the integration of enhanced recovery after surgery (ERAS) protocols into complex oncologic procedures. His research centers on optimizing perioperative care and surgical techniques for bladder, kidney, and prostate cancers. Kameyama’s most cited work (2023, 9 citations) demonstrates that combining ERAS with robot-assisted radical cystectomy (RARC) improves recovery outcomes for muscle-invasive bladder cancer, challenging traditional open-surgery paradigms. He further refined nephron-sparing surgery by evaluating off-clamp open partial nephrectomy without renorrhaphy for ≥T1b renal tumors (2021, 7 citations), reducing ischemia-related kidney damage. His early implementation of ERAS during robot-assisted radical prostatectomy (2023, 3 citations) extends these benefits to prostate cancer care, shortening hospital stays and lowering complications. By systematically applying multidisciplinary perioperative protocols—originally developed for gastrointestinal surgery—to urology, Kameyama bridges a critical gap in the field. His work not only validates the safety and efficacy of ERAS in robotic urologic oncology but also sets a new standard for patient-centered recovery. For students and researchers, Kameyama exemplifies how surgical innovation and evidence-based perioperative care can transform outcomes in high-stakes cancer surgery.